1. Home
  2. TG vs STTK Comparison

TG vs STTK Comparison

Compare TG & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$6.85

Market Cap

239.6M

Sector

Industrials

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.08

Market Cap

792.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
STTK
Founded
1988
2016
Country
United States
United States
Employees
1700
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.6M
792.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TG
STTK
Price
$6.85
$6.08
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$10.00
AVG Volume (30 Days)
136.2K
756.8K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
53.02
EPS
0.34
N/A
Revenue
$800,821,000.00
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.09
N/A
Revenue Growth
8.29
N/A
52 Week Low
$6.25
$1.70
52 Week High
$10.53
$8.33

Technical Indicators

Market Signals
Indicator
TG
STTK
Relative Strength Index (RSI) 32.43 37.50
Support Level N/A $5.87
Resistance Level $8.10 $7.75
Average True Range (ATR) 0.25 0.30
MACD -0.09 -0.10
Stochastic Oscillator 30.00 21.33

Price Performance

Historical Comparison
TG
STTK

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: